EUVIMEDEUVIMED entdecken
Crossref

Model for end-stage liver disease incorporating albumin score is associated with short- and long-term all-cause mortality in patients with acute myocardial infarction complicated by cardiogenic shock

Zakaria Alaoui-Ismaili iD, Joakim Bo Kunkel iD, Anika Klein iD, Jakob Josiassen iD, Ole Kristian Lerche Helgestad iD, Karoline Korsholm Jeppesen iD, Henrik Schmidt iD, Lene Holmvang iD, Peter Laursen Graversen iD, Emil Fosbøl iD, Hanne Berg Ravn iD, Lisette Okkels Jensen iD und 2 weitere

European Heart Journal: Acute Cardiovascular Care · 2025

DOI: 10.1093/ehjacc/zuaf063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Heart Journal: Acute Cardiovascular Care, 2025. Verfasst von Zakaria Alaoui-Ismaili und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 København, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Shock, Cardiogenic, Myocardial Infarction, End Stage Liver Disease, Serum Albumin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Danish Heart Foundation, Odense University Hospital, Rigshospitalet Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Liver injury is a frequent complication in patients with acute myocardial infarction complicated by cardiogenic shock (AMICS). The model for end-stage liver disease incorporating albumin (MELD-albumin) quantifies liver injury. This study assesses the association between MELD-albumin score and all-cause mortality among patients with AMICS. Methods and results From a retrospective cohort of 1716 consecutive patients with AMICS admitted between 2010 and 2017, we included patients who survived until Day 3 and had complete laboratory data available (n = 717). The MELD-albumin was calculated using 0 to 72 h peak s-bilirubin and s-creatinine values and the lowest s-albumin value. Patients were stratified into tertiles: low, intermediate, and high MELD-albumin. The primary outcome was all-cause mortality with a follow-up of up to 14 years. Patients in the high-score group were more often female, had lower left ventricular ejection fraction, had higher lactate levels, and less suffered out-of-hospital cardiac arrest. The high-score group had a significantly higher all-cause mortality rate than the intermediate- and low-score groups at 30 days (49 vs. 35 vs. 26%, P < 0.001) and 10 years for 30-day survivors (58 vs. 46 vs. 37%, P < 0.001). Adjusted hazard ratios for mortality in the high-score group were 2.02 at 30 days [95% confidence interval (CI): 1.49–2.74, P < 0.001] and 1.86 at 10 years (95% CI: 1.18–2.92, P < 0.001). The MELD-albumin score demonstrated an area under the receiver operating curve of 0.63 (95% CI: 0.59–0.67) for predicting 30-day mortality.

Conclusion

Liver injury, quantified as MELD-albumin score, was significantly associated with short- and long-term all-cause mortality among patients with AMICS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Shock, CardiogenicMyocardial InfarctionEnd Stage Liver DiseaseSerum AlbuminHumansFemaleMaleRetrospective StudiesAgedSurvival RateMiddle AgedCause of DeathPrognosisFollow-Up StudiesTime FactorsRisk Factors

Stichwörter der Autor:innen

Acute myocardial infarctionAlbuminCardiogenic shockLiver injuryModel for end-stage liver diseaseMortality

Substanzen

Serum Albumin

Autor:innen und Institutionen

  • Department of Cardiology, Copenhagen University Hospital, Rigshospitalet, Blegdamsvej 9, 2100 København, Copenhagen, Denmark.
  • Department of Cardiology, Odense University Hospital, J. B. Winsløws Vej 4, 5000 Odense, Denmark.
  • Department of Cardiothoracic Anaesthesia, Odense University Hospital, J. B. Winsløws Vej 4, 5000 Odense, Denmark.

ORCID-Profile: Zakaria Alaoui-Ismaili, Joakim Bo Kunkel, Anika Klein, Jakob Josiassen, Ole Kristian Lerche Helgestad, Karoline Korsholm Jeppesen, Henrik Schmidt, Lene Holmvang, Peter Laursen Graversen, Emil Fosbøl, Hanne Berg Ravn, Lisette Okkels Jensen, Jacob Eifer Møller, Christian Hassager

Förderung

  • Danish Heart Foundation
  • Odense University Hospital
  • Rigshospitalet Research Fund
  • Abiomed
  • Novo Nordic Foundation
  • Boston Scientific
  • Lundbeck Foundation

Zitieren

APA

Alaoui-Ismaili, Z., Bo Kunkel, J., Klein, A., Josiassen, J., Kristian Lerche Helgestad, O., Korsholm Jeppesen, K., Schmidt, H., Holmvang, L., Graversen, P. L., Fosbøl, E., Ravn, H. B., Okkels Jensen, L., Eifer Møller, J., & Hassager, C. (2025). Model for end-stage liver disease incorporating albumin score is associated with short- and long-term all-cause mortality in patients with acute myocardial infarction complicated by cardiogenic shock. European Heart Journal: Acute Cardiovascular Care. https://doi.org/10.1093/ehjacc/zuaf063

Vancouver

Alaoui-Ismaili Z, Bo Kunkel J, Klein A, Josiassen J, Kristian Lerche Helgestad O, Korsholm Jeppesen K, et al. Model for end-stage liver disease incorporating albumin score is associated with short- and long-term all-cause mortality in patients with acute myocardial infarction complicated by cardiogenic shock. European Heart Journal: Acute Cardiovascular Care. 2025. doi:10.1093/ehjacc/zuaf063

BibTeX
@article{AlaouiIsmaili2025,
  author = {Alaoui-Ismaili, Zakaria and Bo Kunkel, Joakim and Klein, Anika and Josiassen, Jakob and Kristian Lerche Helgestad, Ole and Korsholm Jeppesen, Karoline and Schmidt, Henrik and Holmvang, Lene and Graversen, Peter Laursen and Fosbøl, Emil and Ravn, Hanne Berg and Okkels Jensen, Lisette and Eifer Møller, Jacob and Hassager, Christian},
  title = {Model for end-stage liver disease incorporating albumin score is associated with short- and long-term all-cause mortality in patients with acute myocardial infarction complicated by cardiogenic shock},
  journal = {European Heart Journal: Acute Cardiovascular Care},
  year = {2025},
  doi = {10.1093/ehjacc/zuaf063}
}
Kostenlos starten →